Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis

Abstract Background Skin barrier dysfunction plays a key role in atopic dermatitis (AD). This impairment is related to altered composition and metabolism of epidermal sphingolipids and a deficiency of ceramides. Glycosaminoglycans (GAGs), and especially hyaluronic acid, could be useful in the manage...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rosanna Marsella, Sergi Segarra, Kim Ahrens, Cristina Alonso, Lluís Ferrer
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2020-03-01
Edice:BMC Veterinary Research
Témata:
Epidermal sphingolipids
Atopic dermatitis
Hyaluronic acid
Sphingomyelin
Animal model
On-line přístup:http://link.springer.com/article/10.1186/s12917-020-02306-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky